Immuneering Corporation Shareholders' Equity
Immuneering Corporation (IMRX) had Shareholders' Equity of $190.74 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $190.74M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $206.52M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $218.48M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $227.98M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $190.74M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $206.52M 10-Q · filed 2026-08-05 |
| 2025-12-31 | $218.48M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $227.98M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $28.94M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $41.84M 10-Q · filed 2026-08-05 |
| 2024-12-31 | $41.39M 10-Q · filed 2026-08-05 |
| 2024-09-30 | $57.72M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $66.31M 10-Q · filed 2025-11-12 |
| 2024-03-31 | $78.72M 10-Q · filed 2025-11-12 |
| 2023-12-31 | $90.58M 10-K · filed 2026-03-06 |
| 2023-09-30 | $104.02M 10-Q · filed 2024-11-13 |
| 2023-06-30 | $115.10M 10-Q · filed 2024-11-13 |
| 2023-03-31 | $97.79M 10-Q · filed 2024-11-13 |
| 2022-12-31 | $109.85M 10-K · filed 2025-03-20 |
| 2022-09-30 | $121.89M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $133.59M 10-Q · filed 2023-11-09 |
| 2022-03-31 | $144.06M 10-Q · filed 2023-11-09 |
| 2021-12-31 | $155.98M 10-K · filed 2024-03-01 |
| 2021-09-30 | $158.29M 10-Q · filed 2022-11-10 |
| 2021-06-30 | -$35.19M 10-Q · filed 2022-11-10 |
| 2021-03-31 | -$28.53M 10-Q · filed 2022-11-10 |
| 2020-12-31 | -$22.48M 10-K · filed 2023-03-06 |
| 2020-09-30 | -$16.86M 10-Q · filed 2021-11-09 |
| 2020-06-30 | -$12.77M 10-Q · filed 2021-11-09 |
| 2020-03-31 | -$9.46M 10-Q · filed 2021-11-09 |
| 2019-12-31 | -$6.53M 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |